Research  >  Research  >  Scientist Profiles

Scientist profiles M-R

SRI profiles

James Perry photo
James Perry, MD, FRCPC

Affiliate scientist

Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room A4 55
Toronto, ON
M4N 3M5

Phone: 416-480-6100 ext. 61960
Fax: 416-480-6002

Administrative Assistant: Lyn Sarceda
Phone: 416-480-6100 ext. 61960

Clinical profile

Show/hide details

Dr. James Perry is a neuro-oncologist at Sunnybrook’s Odette Cancer Centre and Hurvitz Brain Sciences Program. Dr. Perry is also a Professor of medicine at the University of Toronto and the central nervous system cancers lead at Cancer Care Ontario.

Research profile

Show/hide details


  • B.Sc. (Hons), 1985, University of Toronto, Canada
  • MD, 1989, U of T, Canada
  • FRCPC, 1993, neurology
  • Diploma in clinical epidemiology, U of T
  • Neuro-oncology fellowship, Duke University, North Carolina

Appointments and Affiliations:

Research Focus:

  • Translational research in brain tumour therapy

Research Summary:

Dr. Perry is a clinician-investigator interested in the design, conduct and analysis of clinical trials testing innovative therapies for primary brain tumours. His research unit is focused on outcomes research. He is the chair of the Canadian Brain Tumour Consortium (CBTC), a national not-for-profit investigator network. He has held leadership roles in the following international collaborative clinical trials:

  • PRODIGE trial: an international, Phase 3 randomized controlled trial testing the safety and efficacy of long-term thromboprophylaxis in patients with malignant glioma. Dr. Perry was the global principal investigator (PI) and heads the steering committee.
  • RESCUE study: a trial testing low-dose protracted temozolomide chemotherapy in recurrent brain tumours. He is the PI for this study.
  • NCIC-CTG CE6 study of treatment for elderly patients with glioblastoma. Perry is the global co-PI.

Selected Publications:

See current publications list at PubMed.

Related News and Stories:

Related Links: